Related Experiment Videos

Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules

H Singh-Jasuja1, R E Toes, P Spee

  • 1Institute for Cell Biology, Department of Immunology, University of Tübingen, Germany.

Insights

Heat shock proteins like glycoprotein 96 (gp96) require specific receptor uptake by antigen-presenting cells (APCs) to activate cytotoxic T lymphocytes (CTLs). This receptor-mediated process is crucial for gp96-chaperoned peptide cross-presentation and subsequent CTL responses.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Heat shock proteins (HSPs), including glycoprotein 96 (gp96), are known to elicit cytotoxic T lymphocyte (CTL) responses.
  • The precise mechanisms by which gp96 facilitates antigen presentation and CTL activation remain under investigation.

Purpose of the Study:

  • To elucidate the role of receptor-mediated uptake in gp96-chaperoned peptide presentation.
  • To identify the cell types capable of binding and internalizing gp96.
  • To understand how gp96 facilitates cross-presentation of cellular antigens.

Main Methods:

  • Investigated gp96 binding and uptake by antigen-presenting cells (APCs) in human and mouse models.
  • Utilized receptor-mediated endocytosis assays and co-localization studies with MHC molecules.
  • Assessed CTL activation using gp96 isolated from cells expressing specific epitopes and inhibitory controls.

Main Results:

  • Specific receptor-mediated uptake of gp96 by professional APCs (dendritic cells, macrophages, B cells) is essential for CTL activation.
  • gp96 is rapidly internalized by APCs and co-localizes with MHC class I and II molecules.
  • gp96-associated peptides are presented in an MHC class I-restricted manner, leading to specific CTL activation.

Conclusions:

  • Receptor-mediated endocytosis of gp96 by APCs is critical for the cross-presentation of cellular antigens.
  • This process enables the induction of specific CTL responses against cellular targets.
  • The findings clarify the molecular mechanisms underlying gp96-mediated immune surveillance and anti-tumor immunity.

Related Concept Videos